OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy
Xian-Miao Li, Zhenyu Zhao, Yu Xiao, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Xian-Miao Li, Zhenyu Zhao, Yu Xiao, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Showing 14 citing articles:
Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs
Qi Zhao, Hong Zong, Pingping Zhu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Qi Zhao, Hong Zong, Pingping Zhu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 11
E3 ligase TRIM28 promotes anti-PD-1 resistance in non-small cell lung cancer by enhancing the recruitment of myeloid-derived suppressor cells
Manman Liang, Zhengui Sun, Xingwu Chen, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 18
Manman Liang, Zhengui Sun, Xingwu Chen, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 18
Phase separation-mediated biomolecular condensates and their relationship to tumor
Xi Wang, Jiameng Liu, Chaoming Mao, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Xi Wang, Jiameng Liu, Chaoming Mao, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
UBR5 in Tumor Biology: Exploring Mechanisms of Immune Regulation and Possible Therapeutic Implications in MPNST
Diana Odhiambo, Shuangyi Fan, Angela C. Hirbe
Cancers (2025) Vol. 17, Iss. 2, pp. 161-161
Open Access
Diana Odhiambo, Shuangyi Fan, Angela C. Hirbe
Cancers (2025) Vol. 17, Iss. 2, pp. 161-161
Open Access
Crosstalk between O-GlcNAcylation and ubiquitination: a novel strategy for overcoming cancer therapeutic resistance
Kai Sun, Yuan Zhi, Wenhao Ren, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Kai Sun, Yuan Zhi, Wenhao Ren, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Role of Ubiquitination and Epigenetics in the Regulation of AhR Signaling in Carcinogenesis and Metastasis: “Albatross around the Neck” or “Blessing in Disguise”
Ammad Ahmad Farooqi, Venera Rakhmetova, Gulnara Kapanova, et al.
Cells (2023) Vol. 12, Iss. 19, pp. 2382-2382
Open Access | Times Cited: 3
Ammad Ahmad Farooqi, Venera Rakhmetova, Gulnara Kapanova, et al.
Cells (2023) Vol. 12, Iss. 19, pp. 2382-2382
Open Access | Times Cited: 3
Targeting the Interplay of Independent Cellular Pathways and Immunity: A Challenge in Cancer Immunotherapy
Angela Lauriola, Pierpaola Davalli, Gaetano Marverti, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 3009-3009
Open Access | Times Cited: 3
Angela Lauriola, Pierpaola Davalli, Gaetano Marverti, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 3009-3009
Open Access | Times Cited: 3
E3 ubiquitin ligases in lung cancer: Emerging insights and therapeutic opportunities
Bhaskar Basu, Satadeepa Kal, Subhajit Karmakar, et al.
Life Sciences (2023) Vol. 336, pp. 122333-122333
Closed Access | Times Cited: 2
Bhaskar Basu, Satadeepa Kal, Subhajit Karmakar, et al.
Life Sciences (2023) Vol. 336, pp. 122333-122333
Closed Access | Times Cited: 2
Comprehensive Analysis of the SUMO-related Signature: Implication for Diagnosis, Prognosis, and Immune Therapeutic Approaches in Cervical Cancer
Xing Zhang, Jian Cao, Xiuting Li, et al.
Biochemical Genetics (2024) Vol. 62, Iss. 6, pp. 4654-4678
Closed Access
Xing Zhang, Jian Cao, Xiuting Li, et al.
Biochemical Genetics (2024) Vol. 62, Iss. 6, pp. 4654-4678
Closed Access
Advantages and Disadvantages of PROTACs
Rohini Pujari, Shvetank Bhatt, Urvashi Soni, et al.
(2024), pp. 67-88
Closed Access
Rohini Pujari, Shvetank Bhatt, Urvashi Soni, et al.
(2024), pp. 67-88
Closed Access
Emerging druggable targets for immune checkpoint modulation in cancer immunotherapy: the iceberg lies beneath the surface
Sakuntala Gayen, Swarupananda Mukherjee, Sandipan Dasgupta, et al.
APOPTOSIS (2024)
Closed Access
Sakuntala Gayen, Swarupananda Mukherjee, Sandipan Dasgupta, et al.
APOPTOSIS (2024)
Closed Access
Mechanistic Insights and Molecular Diagnostics of TMPRSS2-ERG: Overview of the Journey from Regulation of Signaling Landscape in Fusion Positive Prostate Cancer to Appraisal as a Diagnostic Marker
Ammad Ahmad Farooqı, Assiya Turgambayeva, Aigul Almabayeva, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 10
Open Access
Ammad Ahmad Farooqı, Assiya Turgambayeva, Aigul Almabayeva, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 10
Open Access
Deletion of CUL4B in gut epithelium promotes ApcMin/+ adenoma formation by impacting the microenvironment
Beibei Guo, Yawen Zheng, Yujia Fan, et al.
Research Square (Research Square) (2023)
Closed Access
Beibei Guo, Yawen Zheng, Yujia Fan, et al.
Research Square (Research Square) (2023)
Closed Access
